Therapeutic-New Use or Method of Treatment

(Total records found: 11)

Tech ID Technology Summary Available? TTO Contact 2002.110H Production of Human Recombinant Cystathionine Beta Synthase:Therapeutic Applications Yes, download David Poticha 9061H Use of Bryostatins and Bryostain Derivates to Treat Pulmonary and Systemic Vascular Diseases Yes, download David Poticha CU1383H Bumetanide For Treatment Of Neonatal Seizures No, contact TTO Rick Silva CU1383H Bumetanide For Treatment Of Neonatal Seizures No, contact TTO Rick Silva CU1543B Linoleic Acid as Dietary Supplement for Prevention and Treatment of Heart Failure Yes, download Kate Tallman CU1593H Prevention of Salivary Gland Hypofunction by Suppression of Apoptosis Yes, download David Poticha CU1653H A Membrane Sealant for Muscular Dystrophy No, contact TTO Rick Silva CU1653H A Membrane Sealant for Muscular Dystrophy No, contact TTO Rick Silva CU1946H Administration of Selective HDAC Inhibitors for Synergistic Cancer Cell Death Yes, download David Poticha CU1968C Inhibition of Fatty Acid Oxidation (FAO) to potentiate drug sensitivity in breast cancer No, contact TTO David Poticha CU2030H Synergistic Response of Sorafenib in Combination with HDAC Inhibitors in Solid Tumors and Predi No, contact TTO David Poticha

(Important: CU may have newer technologies available in this area that are not yet listed here. To find out about other opportunities in Therapeutic-New Use or Method of Treatment, contact Lindsay Polak at lindsay.polak@cu.edu, or by phone at (303) 735-5518. Thank you.)